Pluvicto (lutetium Lu 177 vipivotide tetraxetan) - Novartis
Can [ 68 Ga]Ga-PSMA PET Data Improve the Automatic Tumour Segmentation in Multi-Timepoint [ 177 Lu]Lu-PSMA SPECT? (EANM 2026) - Sep 29, 2026 - Abstract #OP-159; Pres time: Oct 18, 2026; 03:00 PM - 04:30 PM; Location: Hall B; "Materials and 331 [177Lu]Lu-PSMA-617 SPECT/CT images of 37 prostate cancer patients (114 administrations) were retrospectively included... Data augmentation with [68Ga]Ga-PSMA PET/CT can significantly improve lesion detection and segmentation performance in multi-timepoint [177Lu]Lu-PSMA SPECT/CT. These results suggest that leveraging PET datasets can effectively compensate for limited SPECT training data, enhancing the robustness of automatic dosimetry pipelines in radioligand therapy." 
Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
https://www.sciencedirect.com/science/article/pii/S3051291326002855?via%3Dihub
 
L. Castelbranco Silva; C. S. Constantino; P. Ferreira; Â. F. Silva; D. Rombo; F. P. M. Oliveira; D. C. Costa
 
Sep 29, 2026
 
Prev Next